GLENN FREDENBURG: Open Payments
NPI 1679152664 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 36 payments from 12 companies in 2025. Trend: 2023 $1,726 · 2024 $902 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $225 |
| Novo Nordisk Inc | 4 | $86 |
| ABBVIE INC. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $57 |
| Lundbeck LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: REXULTI, FARXIGA, Ozempic, AIRSUPRA, QULIPTA, BREZTRI, MOUNJARO, Auvelity.
Industry payments across NY — which companies pay providers there.
